The rising geriatric population to boost the Varicose Veins Treatment Market growth

 

Varicose Veins Treatment Market 

The Varicose Veins Treatment Devices Market is segmented by Treatment Type (Endovenous Ablation, Injection Sclerotherapy, and Surgical Ligation/Stripping), Product (Ablation Devices (Radiofrequency Ablation Devices and Laser Ablation Devices), Venous Closure Products, and Surgical Products), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

The global Varicose Veins Treatment Market is estimated to be valued at US$ 1,273.0 million in 2022 and is expected to exhibit a CAGR of 6.5% during the forecast period (2022-2030).

Market Overview:

Varicose veins are perverted, inflated veins. Any vein that is nearer to the skin's surface can become varicose. Varicose veins generally impact the veins in the lower extremities. That's because standing and walking rises the burden in the veins of the lower extremity.

Competitive Landscape:

Key players involved in the x are Quanta System, Medtronic plc, AngioDynamics Inc., Syneron Medical Ltd, Biolitec AG, Teleflex incorporated, Lumenis, and Vascular Solutions Inc.

Market Key Drivers:

The rising geriatric population is expected to augment the growth of the global varicose veins treatment market. For instance, as per WHO, around 80% of the population would be geriatric by 2050.

The rising incidence of varicose veins is projected to propel the growth of the global varicose veins treatment market.  For instance, as per a report by BMC Nursing in February 2020, varicose veins are known to be one of the most chronic venous diseases, distressing 20-60% of all adults across the globe.

Covid-19 Impact Analysis:

The outbreak of COVID-19 is has adversely affected the growth of global varicose veins treatment market. As the concentration of hospital staff and doctors has been transferred towards the therapy of COVID-19-infected patients. Hence, the treatment of non-emergency medical problems was given less priority which impeded the market growth.

Key Takeaways:

The global varicose veins treatment market is expected to exhibit a CAGR of XX % during the forecast period due rising investments, acquisitions and launches. For instance In May 2022, THERACLION, has introduced SONOVEIN HD. This method gathers SuperSonic Imagine's cutting-edge imaging abilities with the initial and only extracorporeal therapeutic ultrasound method.

Among region North America, Asia Pacific and Europe are anticipated to witness robust growth in the global varicose veins treatment market due to rising incidences of varicose veins, increasing adoption and quick product launches. For instance, as per Clinical Epidemiology and Global Health in December 2021, varicose veins affect around 23% of people in U.S.